Extract from the Register of European Patents

EP About this file: EP0452809

EP0452809 - A therapeutic agent for pollakiuria, urinary urgency or incontinence of urine comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives [Right-click to bookmark this link]
Former [1991/43]A therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives
[1994/30]
StatusNo opposition filed within time limit
Status updated on  01.06.1995
Database last updated on 01.04.2026
Most recent event   Tooltip03.05.2002Lapse of the patent in a contracting state
New state(s): ES
published on 19.06.2002  [2002/25]
Applicant(s)For all designated states
FUJISAWA PHARMACEUTICAL CO., LTD.
4-7, Doshomachi 3-chome Chuo-ku Osaka-shi
Osaka 541-8514 / JP
[N/P]
Former [1991/43]For all designated states
FUJISAWA PHARMACEUTICAL CO., LTD.
4-7, Doshomachi 3-chome Chuo-ku
Osaka-shi Osaka 541 / JP
Inventor(s)01 / Tomoi, Masaaki
3-5-65-1214, Nishiiwata
Higashiosaka-shi, Osaka 578 / JP
[1991/43]
Representative(s)Türk, Dietmar
Türk, Gille, Hrabal, Leifert Patentanwälte Brucknerstrasse 20
40593 Düsseldorf / DE
[N/P]
Former [1991/43]Türk, Dietmar, Dr. rer. nat.
Türk, Gille, Hrabal, Leifert Patentanwälte Brucknerstrasse 20
D-40593 Düsseldorf / DE
Application number, filing date91105753.711.04.1991
[1991/43]
Priority number, dateJP1990010390318.04.1990         Original published format: JP 10390390
[1991/43]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0452809
Date:23.10.1991
Language:EN
[1991/43]
Type: A3 Search report 
No.:EP0452809
Date:15.04.1992
Language:EN
[1992/16]
Type: B1 Patent specification 
No.:EP0452809
Date:27.07.1994
Language:EN
[1994/30]
Search report(s)(Supplementary) European search report - dispatched on:EP27.02.1992
ClassificationIPC:A61K31/44
[1991/43]
CPC:
A61K31/44 (EP,KR,US); A61P13/02 (EP); A61P15/00 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1991/43]
TitleGerman:Therapeutisches Mittel gegen Pollakiurie, Harndrang oder Harninkontinenz, das alpha-Phenyl-alpha-Pyridylalkan-Carbonsäurederivate enthält[1994/30]
English:A therapeutic agent for pollakiuria, urinary urgency or incontinence of urine comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives[1994/30]
French:Agent thérapeutique pour le traitement de la pollakiurie, urgence urinaire ou incontinence d'urine contenant des dérivés de l'acide alpha-phényl-alpha-pyridyl-alcanoique[1994/30]
Former [1991/43]Therapeutisches Mittel gegen Dysurie, das alpha-Phenyl-alpha-Pyridylalkan-Carbonsäurederivate enthält
Former [1991/43]A therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives
Former [1991/43]Agent thérapeutique pour le traitement de la dysurie contenant des dérivés de l'acide alpha-phényl-alpha-pyridyl-alcanoique
Examination procedure07.10.1992Examination requested  [1992/50]
23.02.1993Despatch of a communication from the examining division (Time limit: M04)
01.07.1993Reply to a communication from the examining division
10.09.1993Despatch of communication of intention to grant (Approval: Yes)
26.01.1994Communication of intention to grant the patent
26.04.1994Fee for grant paid
26.04.1994Fee for publishing/printing paid
Opposition(s)28.04.1995No opposition filed within time limit [1995/29]
Fees paidRenewal fee
13.04.1993Renewal fee patent year 03
11.04.1994Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipES27.07.1994
NL27.07.1994
[2002/25]
Former [1995/15]NL27.07.1994
Documents cited:Search[Y]   THE AMERICAN JOURNAL OF SURGERY, vol. 145, no. 5, May 1983, pages 558-561; J.D. GIESY et al.: "Micturition neuropharmacology" [Y]
 [Y]   CLINICS IN OHSTETRICS AND GYNAECOLOGY, vol. 8, no. 1, April 1981, pages 149-160, W.B. Saunders Co., Ltd; F.B. GIBBERD: "The neurogenic bladder" [Y]
 [Y]   ARCH. INTERN. MED., vol. 143, September 1983, pages 1683-1686; L.H. DANZIGER et al.: "Disopyramide-induced urinary retention" [Y]
 [A]   W. PSCHYREMBEL: "Klinisches Wrterbuch", 1977, page 279, Walter de Gruyter, Berlin, DE [A]
 [A]   The Merck Manual, 15th edition, 1987, page 1553, edited by R. BERKOW et al., Merck & Co., Inc., Rahway, NJ, US [A]
 [A]   W.A. DORLAND: "Dorland's Illustrated Medical Dictionary", 26th edition, 1985, page 416, W.B. Saunders & Cie, Philadelphia, US [A]
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.